LEE PHARMACEUTICALS (LPHM)
LPHM moved a median of +10.56% 30 minutes after news, and +9.54% by the close. How LPHM actually reacts to news — the realized, point-in-time move the market made, measured across 51 labeled events over its full measured history with zero look-ahead.
LPHM’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 27% | 15 |
| 30-min | +10.56% | 56% | 16 |
| 60-min | +7.50% | 63% | 16 |
| to close | +9.54% | 63% | 16 |
| Middle 50% of LPHM reactions | 0.00% to +25.12% |
|---|---|
| Median reaction (30-min) | +10.56% |
| Measured reactions | 51 |
Half of all LEE PHARMACEUTICALS news events land between +0.00% and +25.12% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when LPHM moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to LPHM's baseline. Nothing else.
Recent LPHM events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| The GLP-1 Era Has a Trust Problem - AimwellBio is Building the Physician Network to Solve It | Press release | ACCESS Newswire | — | — | |
| AimwellBio Puts Its Global Intelligence Map in Public View, No Login Required, as Dr. Chris A. Jones Builds Out the Advisory Bench Behind it | Press release | ACCESS Newswire | — | — | |
| The IP Was Only Half the Acquisition: Aimwell Bio Closes the Trustr IP Purchase and Begins Bringing Aboard the People Who Built It | Press release | ACCESS Newswire | — | — | |
| AimwellBio Secures Patented Behavioral AI Portfolio Backed by Oxford Science and Sanofi Pilot; Inventor Dr. Chris A. Jones Joins Board of Advisors | Press release | ACCESS Newswire | — | — | |
| AimwellBio Publishes Investor Briefing on Acquired Trustr Intellectual Property Portfolio Valued at $10m Reinforcing Commitment to Transparency | Press release | ACCESS Newswire | — | — | |
| Aimwell Partners Announces Agreement in Principle to Acquire Intellectual Property Valued at Approximately $10 Million | Press release | ACCESS Newswire | — | — | |
| The World's Most Valuable Healthcare Database May Already Exist, The Problem Is Nobody Knows Who to Trust Inside It | Press release | ACCESS Newswire | — | — | |
| Aimwell Partners Inc. (OTC: AIMN) Opens No-Cost Observer Access and Publishes The Standard Behind Its Verified Intelligence Platform | Press release | ACCESS Newswire | — | — | |
| The Doctors Who Actually Know Things Have Spent Twenty Years Being Cited and Never Credited. Aimwell Partners Inc. Is Building the Network That Puts Their Names on the Record | Press release | ACCESS Newswire | — | — | |
| Aimwell Partners Inc. (OTC:AIMN) Confirms Advanced Discussions With Curated Life Sciences Capital Network | Press release | ACCESS Newswire | — | — | |
| Aimwell Partners Inc. (OTC: AIMN) Enters Final Negotiations to Acquire Healthcare Intellectual Property Independently Valued at $10 Million | Press release | ACCESS Newswire | — | — | |
| The Professionals Arrived First - Now Their Institutions are Following: Aimwell Partners Inc. Confirms Enterprise Interest Driven by Its Credentialed Observer Network | Press release | ACCESS Newswire | — | — | |
| Every AI Intelligence Platform Asks the Market to Trust Its Numbers. Aimwell Partners Inc. (OTC:AIMN) Just Opened the Data | Press release | ACCESS Newswire | — | — | |
| Aimwell Partners Inc. Publishes the Adversarial Validation Standard, v1, an Open Methodology Framework for Verifying AI-Generated Biopharma Intelligence | Press release | ACCESS Newswire | — | — | |
| AimwellBio Continues Onboarding Healthcare Professionals to Its Verified Observer Network, Adds One-Click LinkedIn Signup | Press release | ACCESS Newswire | — | — | |
| AIMN: As Healthcare Breaches Hit a Record and Move to Third-Party Providers, AimwellBio.com Explores a Redundancy Layer Built to Survive the Vendor | Press release | ACCESS Newswire | — | — | |
| AimwellBio Expands Platform Capabilities to Strengthen the Infrastructure Behind Trusted Healthcare Intelligence | Press release | ACCESS Newswire | — | — | |
| AimwellBio Opens Verified Observer Network to Healthcare, Research, and Capital Professionals at No Cost | Press release | ACCESS Newswire | — | — | |
| The Question No Telehealth Underwriter Wants Asked: When was Your Platform Last Breached, and Would You Even Know? | Press release | ACCESS Newswire | — | — | |
| As Healthcare's Software Leaders Race to Add AI, AimwellBio.com Moves to Build the Layer That Verifies It | Press release | ACCESS Newswire | — | — | |
| AimwellBio Opens a Door Most People Will Not Be Allowed Through, And Healthcare's Sharpest Professionals Are Already Walking In | Press release | ACCESS Newswire | — | — | |
| Why a Verified Biopharma Intelligence Network Is Quietly Becoming the Credential Itself | Press release | ACCESS Newswire | — | — | |
| The Quiet Restructuring of Healthcare Intelligence: Why the Industry is Moving Toward Verified Professional Networks Over Anonymous AI | Press release | ACCESS Newswire | — | — | |
| Inside AimwellBio's Federated Health Intelligence Network: Verified Clinical Intelligence Model Gains Attention Among Physicians | Press release | ACCESS Newswire | — | — | |
| The Doctors Saw It First. Then the Chiropractors Asked. Now AimwellBio is Adding the Four Signals Every Family in America is Quietly Searching For. | Press release | ACCESS Newswire | — | — | |
| Aimwell Partners Brand, AimwellBio Announces Expanded FHIN Intelligence Framework, Early Demo Feedback, and New AIMN Development Milestones | Press release | ACCESS Newswire | — | — | |
| While You Were in That Meeting, 14 Signals Moved. Your Competitors Saw Them. You Didn’t. | Press release | ACCESS Newswire | — | — | |
| AimwellBio Reports Strong Early Demand From Hospital Systems and Researchers as FHIN Founding Cohort Takes Shape | Press release | ACCESS Newswire | — | — | |
| AimwellBio Launches Verified Intelligence Layer for Healthcare as AI Hallucination Risk Reaches Clinical Settings | Press release | ACCESS Newswire | — | — | |
| Aimwell Bio Expands FHIN Deployment Across U.S. and Australia as Clinical Leaders Move to Replace Unverified AI Hospitalists and Physician Groups Drive Demand for Source-Traceable Intelligence Infrastructure | Press release | ACCESS Newswire | — | — | |
| Aimwell Bio Announces "Founding Cohort" of Federated Health Intelligence Network (FHIN); Tackles 38% AI Hallucination Rate in Biopharma | Press release | ACCESS Newswire | — | — |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the LPHM section they belong to.
Where else LPHM is measured.
LPHM earnings → · Analyst actions → · SEC filings →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is LEE PHARMACEUTICALS's median reaction calculated?
Every labeled LPHM news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 51 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 56% of LPHM's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does LPHM's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.